These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26443019)

  • 41. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.
    Rayment JH; Stanojevic S; Davis SD; Retsch-Bogart G; Ratjen F
    Thorax; 2018 May; 73(5):451-458. PubMed ID: 29449440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.
    Equi A; Balfour-Lynn IM; Bush A; Rosenthal M
    Lancet; 2002 Sep; 360(9338):978-84. PubMed ID: 12383667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy.
    Wientzen R; Prestidge CB; Kramer RI; McCracken GH; Nelson JD
    Am J Dis Child; 1980 Dec; 134(12):1134-8. PubMed ID: 7004176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis.
    Hyatt AC; Chipps BE; Kumor KM; Mellits ED; Lietman PS; Rosenstein BJ
    J Pediatr; 1981 Aug; 99(2):307-14. PubMed ID: 7019407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis.
    Salh B; Bilton D; Dodd M; Abbot J; Webb K
    Scand J Infect Dis; 1992; 24(2):215-8. PubMed ID: 1641599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
    Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
    Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.
    Stanojevic S; McDonald A; Waters V; MacDonald S; Horton E; Tullis E; Ratjen F
    Thorax; 2017 Apr; 72(4):327-332. PubMed ID: 27539619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of upper respiratory tract infections in patients with cystic fibrosis.
    Collinson J; Nicholson KG; Cancio E; Ashman J; Ireland DC; Hammersley V; Kent J; O'Callaghan C
    Thorax; 1996 Nov; 51(11):1115-22. PubMed ID: 8958895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial.
    Barffour MA; Hinnouho GM; Wessells KR; Kounnavong S; Ratsavong K; Sitthideth D; Bounheuang B; Sengnam K; Chanhthavong B; Arnold CD; Brown KH; Larson CP; Hess SY
    J Glob Health; 2020 Jun; 10(1):010424. PubMed ID: 32612816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.
    Schechter MS; VanDevanter DR; Pasta DJ; Short SA; Morgan WJ; Konstan MW;
    Ann Am Thorac Soc; 2018 Feb; 15(2):225-233. PubMed ID: 29140726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
    Arguedas AG; Stutman HR; Zaleska M; Knupp CA; Marks MI; Nussbaum E
    Am J Dis Child; 1992 Jul; 146(7):797-802. PubMed ID: 1496945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
    Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
    J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.
    Winnie GB; Cowan RG; Wade NA
    J Pediatr; 1989 Feb; 114(2):309-14. PubMed ID: 2915293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations.
    Aronoff SC; Quinn FJ; Carpenter LS; Novick WJ
    J Pediatr; 1994 Dec; 125(6 Pt 1):992-7. PubMed ID: 7996376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of zinc supplementation in the prevention of respiratory tract infections and diarrheal disease in Colombian children: A 12-month randomised controlled trial.
    Martinez-Estevez NS; Alvarez-Guevara AN; Rodriguez-Martinez CE
    Allergol Immunopathol (Madr); 2016; 44(4):368-75. PubMed ID: 27255474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinc supplementation as adjunct therapy in children with measles accompanied by pneumonia: a double-blind, randomized controlled trial.
    Mahalanabis D; Chowdhury A; Jana S; Bhattacharya MK; Chakrabarti MK; Wahed MA; Khaled MA
    Am J Clin Nutr; 2002 Sep; 76(3):604-7. PubMed ID: 12198006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.
    Wagener JS; Rasouliyan L; VanDevanter DR; Pasta DJ; Regelmann WE; Morgan WJ; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):666-73. PubMed ID: 22888106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.
    Eigen H; Rosenstein BJ; FitzSimmons S; Schidlow DV
    J Pediatr; 1995 Apr; 126(4):515-23. PubMed ID: 7699528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.
    Renner S; Rath R; Rust P; Lehr S; Frischer T; Elmadfa I; Eichler I
    Thorax; 2001 Jan; 56(1):48-52. PubMed ID: 11120904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of zinc supplementation on duration of hospitalization in Tanzanian children presenting with acute pneumonia.
    Fataki MR; Kisenge RR; Sudfeld CR; Aboud S; Okuma J; Mehta S; Spiegelman D; Fawzi WW
    J Trop Pediatr; 2014 Apr; 60(2):104-11. PubMed ID: 24194421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.